These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 34895065

  • 1. Long noncoding RNA matrilineal expression gene 3 inhibits hepatocellular carcinoma progression by targeting microRNA-5195-3p and regulating the expression of forkhead box O1.
    Li M, Liao H, Wu J, Chen B, Pang R, Huang J, Zhu Y.
    Bioengineered; 2021 Dec; 12(2):12880-12890. PubMed ID: 34895065
    [Abstract] [Full Text] [Related]

  • 2. CircGNAO1 suppresses hepatocellular carcinoma progression and metastasis via sponging miR-182-5p and regulating FOXO1 expression.
    Ju L, Luo Y, Shan J, Lu R, Chen L, Shao J, Bian Z, Yao M.
    Int Immunopharmacol; 2024 Oct 25; 140():112873. PubMed ID: 39098231
    [Abstract] [Full Text] [Related]

  • 3. High glucose regulates ERp29 in hepatocellular carcinoma by LncRNA MEG3-miRNA 483-3p pathway.
    Li X, Cheng T, He Y, Zhou S, Wang Y, Zhang K, Yu P.
    Life Sci; 2019 Sep 01; 232():116602. PubMed ID: 31251997
    [Abstract] [Full Text] [Related]

  • 4. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y, Liu Z, Yao B, Li Q, Wang L, Wang C, Dou C, Xu M, Liu Q, Tu K.
    Mol Cancer; 2017 Jul 17; 16(1):123. PubMed ID: 28716020
    [Abstract] [Full Text] [Related]

  • 5. Long noncoding RNA 02027 inhibits proliferation, migration and invasion of hepatocellular carcinoma via miR-625-3p/PDLIM5 pathway.
    Wang J, Zhu Y, Ai X, Wan H, Jia W, Chu J, Xu B, Kong X, Kong L.
    J Gene Med; 2023 Jun 17; 25(6):e3485. PubMed ID: 36811210
    [Abstract] [Full Text] [Related]

  • 6. Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis.
    Liu Z, Ouyang G, Lu W, Zhang H.
    Genes Genomics; 2021 Aug 17; 43(8):857-868. PubMed ID: 33843021
    [Abstract] [Full Text] [Related]

  • 7. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
    Guo X, Wang Y.
    Cancer Med; 2020 Jul 17; 9(14):5235-5246. PubMed ID: 32462698
    [Abstract] [Full Text] [Related]

  • 8. lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11.
    Liu Z, Chen JY, Zhong Y, Xie L, Li JS.
    Braz J Med Biol Res; 2019 Jul 17; 52(10):e8631. PubMed ID: 31531526
    [Abstract] [Full Text] [Related]

  • 9. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
    Zhou Q, Zhang W, Wang Z, Liu S.
    BMC Cancer; 2019 Jul 24; 19(1):731. PubMed ID: 31340767
    [Abstract] [Full Text] [Related]

  • 10. Long Noncoding RNA HOTAIR Contributes to Progression in Hepatocellular Carcinoma by Sponging miR-217-5p.
    Gong X, Zhu Z.
    Cancer Biother Radiopharm; 2020 Jun 24; 35(5):387-396. PubMed ID: 32315535
    [Abstract] [Full Text] [Related]

  • 11. ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1.
    Pan G, Zhang J, You F, Cui T, Luo P, Wang S, Li X, Yuan Q.
    Bioengineered; 2022 Jan 24; 13(1):1346-1358. PubMed ID: 34983308
    [Abstract] [Full Text] [Related]

  • 12. Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis.
    Liu Y, Liu J, Cui J, Zhong R, Sun G.
    Bioengineered; 2022 Jan 24; 13(1):1115-1125. PubMed ID: 34978464
    [Abstract] [Full Text] [Related]

  • 13. LINC01018 confers a novel tumor suppressor role in hepatocellular carcinoma through sponging microRNA-182-5p.
    Wang S, Xu M, Sun Z, Yu X, Deng Y, Chang H.
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug 01; 317(2):G116-G126. PubMed ID: 31021172
    [Abstract] [Full Text] [Related]

  • 14. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
    Wu YH, Yu B, Chen WX, Ai X, Zhang W, Dong W, Shao YJ.
    Aging (Albany NY); 2021 Aug 02; 13(15):19260-19271. PubMed ID: 34341185
    [Abstract] [Full Text] [Related]

  • 15. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
    Song EL, Xing L, Wang L, Song WT, Li DB, Wang Y, Gu YW, Liu MM, Ni WJ, Zhang P, Ma X, Zhang X, Yao J, Chen Y, An RH.
    Aging (Albany NY); 2019 Aug 10; 11(15):5705-5725. PubMed ID: 31400752
    [Abstract] [Full Text] [Related]

  • 16. lncRNA-SNHG15 accelerates the development of hepatocellular carcinoma by targeting miR-490-3p/ histone deacetylase 2 axis.
    Dai W, Dai JL, Tang MH, Ye MS, Fang S.
    World J Gastroenterol; 2019 Oct 14; 25(38):5789-5799. PubMed ID: 31636472
    [Abstract] [Full Text] [Related]

  • 17. LncRNA SNHG15 promotes hepatocellular carcinoma progression by sponging miR-141-3p.
    Ye J, Tan L, Fu Y, Xu H, Wen L, Deng Y, Liu K.
    J Cell Biochem; 2019 Dec 14; 120(12):19775-19783. PubMed ID: 31310393
    [Abstract] [Full Text] [Related]

  • 18. MiR-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma.
    Wang Q, Yang X, Zhou X, Wu B, Zhu D, Jia W, Chu J, Wang J, Wu J, Kong L.
    Biochem Biophys Res Commun; 2020 Jun 11; 526(4):889-897. PubMed ID: 32279994
    [Abstract] [Full Text] [Related]

  • 19. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D, Xing N, Yang T, Liu J, Zhao H, He J, Ai Y, Yang J.
    Cancer Med; 2020 Oct 11; 9(19):7218-7230. PubMed ID: 32767662
    [Abstract] [Full Text] [Related]

  • 20. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression.
    Gao W, Chen X, Chi W, Xue M.
    Int J Mol Med; 2020 Nov 11; 46(5):1743-1754. PubMed ID: 33000222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.